Rotavirus News and Research

Latest Rotavirus News and Research

GAVI announces HPV, rubella vaccines will be available to developing countries

"The GAVI Alliance has announced that it will include human papillomavirus (HPV) and combined measles-rubella vaccines in its portfolio for the first time" to help protect women from cervical cancer and children from disability or premature death, Africa Science News reports.

6 Apr 2012

U of S professor receives Canada Gairdner Wightman Award

University of Saskatchewan Professor Emeritus Lorne Babiuk has been awarded the prestigious Canada Gairdner Wightman Award in recognition of his accomplishments over three decades that include leading the U of S Vaccine and Infectious Disease Organization (VIDO) to become a world centre for vaccine research, training and development.

22 Mar 2012

MTPC, Medicago partner to develop and commercialize three new vaccines

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the establishment of a strategic alliance with Mitsubishi Tanabe Pharma Corporation (MTPC) through the execution of a Master Research Collaboration Agreement.

6 Mar 2012

New prebiotic formula helps colonize newborn's gut with beneficial bacteria

Adding prebiotic ingredients to infant formula helps colonize the newborn's gut with a stable population of beneficial bacteria, and probiotics enhance immunity in formula-fed infants, two University of Illinois studies report.

1 Mar 2012

RV5 vaccination does not increase risk of intussusception in infants

Although some data have suggested a possible increased risk of intussusception (when a portion of the small or large intestine slides forward into itself, like a telescope) after administration of the pentavalent rotavirus vaccine in infants, an analysis that included almost 800,000 doses administered to U.S. infants found no increased risk of this condition following vaccination, according to a study in the February 8 issue of JAMA.

8 Feb 2012

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

The rotovirus vaccine was pulled from the marketplace in 1999 after being associated with painful gastrointestinal complications, however, the updated rotavirus vaccines do not appear to increase the occurrence of these potentially fatal side effects, according to a new study by child health experts at C.S. Mott Children's Hospital.

5 Jan 2012

Latin American, Caribbean national rotavirus immunization campaigns show success, CDC report says

"Fourteen of the 32 countries in Latin America and the Caribbean make the rotavirus vaccine available for all infants via national programs," according to a report published Friday in the CDC's "Morbidity and Mortality Weekly Report," United Press International reports.

3 Dec 2011

Sinovac third quarter sales increase 60.8% to $15.4 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for the period ended September 30, 2011.

14 Nov 2011

Second molecular conductor discovered in some children with biliary atresia

Unexpected discovery of a new molecular signature for a destructive and often lethal pediatric liver disease may lead to a new therapeutic target for the hard-to-treat condition.

9 Nov 2011

Private sector companies should contribute to GAVI Matching Fund

The GAVI Alliance has "announced a major new initiative aimed at engaging private sector leaders: the GAVI Matching Fund," through which "the British Government's Department for International Development (DFID) and the Bill & Melinda Gates Foundation will provide a 100 percent match of contributions to GAVI from corporations and foundations as well as their customers, members and employees," Bill Roedy, former CEO of MTV Networks and a GAVI Alliance envoy, writes in a post on the Huffington Post's "Impact" blog.

8 Nov 2011

Kenya aims to reduce preventable deaths by 50% by December 2012

GlobalPost's "Global Pulse" blog examines how Kenya is working to decrease the number of preventable deaths under a "recently launched ... campaign called 'Let's Live,' which sets a target of reducing preventable deaths in Kenya by 50 percent by December 2012."

20 Oct 2011

One in six mobile phones home for E. coli: Study

The London's School of Hygiene and Tropical Medicine released a study in conjunction with the Queen Mary, University of London which suggests that Britons are not doing a good enough job of washing hands. Experts said the most likely reason for the potentially harmful bacteria festering on so many gadgets was people failing to wash their hands properly with soap after going to the toilet.

17 Oct 2011

Experts from CHOP address American Academy of Pediatrics annual meeting

Numerous experts from The Children's Hospital of Philadelphia will be addressing their colleagues at this year's annual meeting of the American Academy of Pediatrics on topics as varied as vaccine education, fetal surgery, sudden cardiac arrest, and sports injuries, among others.

15 Oct 2011

One in six mobile phones in the UK is contaminated with fecal bacteria

One in six mobile phones in Britain is contaminated with faecal matter, according to new research released ahead of Global Handwashing Day.

14 Oct 2011

Study highlights importance of prior planning before introduction of new vaccines

Proper planning before the introduction of new vaccines into a developing country's active immunization program could prevent storage problems and transportation bottlenecks that decrease the availability of existing vaccines by as much as two-thirds, according to a University of Pittsburgh study.

30 Sep 2011

GAVI to purchase $1 billion in childhood vaccines for distribution in 37 of the poorest nations

The Geneva-based GAVI Alliance, a fund backed by governments, the World Bank, the WHO and the Bill & Melinda Gates Foundation, said in an e-mailed statement on Tuesday that it will purchase more than $1 billion in vaccines against rotavirus, pneumococcal and other diseases through deals made with GlaxoSmithKline, Pfizer Inc. and Merck & Co. to immunize children in 37 of the poorest nations, Bloomberg reports.

28 Sep 2011

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

The latest research shows that since the 2006 introduction of routine inoculation against rotavirus -- a leading cause of diarrhea in infants and young children -- almost 65,000 fewer American children have been hospitalized and about $278 million in healthcare costs have been saved.

26 Sep 2011

Vaccinating infants against rotavirus decreases health care use and treatment costs

Vaccinating infants against rotavirus has resulted in dramatic decreases in health care use and treatment costs for diarrhea-related illness in U.S. infants and young children, according to a new study by the Centers for Disease Control and Prevention. The study is published in the current issue of the New England Journal of Medicine.

22 Sep 2011

Infant rotavirus vaccination may provide indirect protection to older children, adults in the U.S.

Vaccinating infants against rotavirus also prevents serious disease in unvaccinated older children and adults, according to a study by the Centers for Disease Control and Prevention.

31 Aug 2011

Rotavirus vaccine still effective in reducing diarrhea-related deaths in Mexico, researchers say

"The rotavirus vaccine introduced in Mexico in 2007 still appears to be preventing diarrhea-related deaths in children, despite speculation that years later the vaccine may not be as effective," according to the Los Angeles Times' "Booster Shots" blog.

26 Aug 2011

Rotavirus News and Research

Latest Rotavirus News and Research

GAVI announces HPV, rubella vaccines will be available to developing countries

U of S professor receives Canada Gairdner Wightman Award

MTPC, Medicago partner to develop and commercialize three new vaccines

New prebiotic formula helps colonize newborn's gut with beneficial bacteria

RV5 vaccination does not increase risk of intussusception in infants

Re-introduction of rotavirus vaccine does not increase intussusception rates in the U.S.

Latin American, Caribbean national rotavirus immunization campaigns show success, CDC report says

Sinovac third quarter sales increase 60.8% to $15.4 million

Second molecular conductor discovered in some children with biliary atresia

Private sector companies should contribute to GAVI Matching Fund

Kenya aims to reduce preventable deaths by 50% by December 2012

One in six mobile phones home for E. coli: Study

Experts from CHOP address American Academy of Pediatrics annual meeting

One in six mobile phones in the UK is contaminated with fecal bacteria

Study highlights importance of prior planning before introduction of new vaccines

GAVI to purchase $1 billion in childhood vaccines for distribution in 37 of the poorest nations

Rotavirus vaccine saved 65,000 hospitalizations and $278 million in healthcare costs: Study

Vaccinating infants against rotavirus decreases health care use and treatment costs

Infant rotavirus vaccination may provide indirect protection to older children, adults in the U.S.

Rotavirus vaccine still effective in reducing diarrhea-related deaths in Mexico, researchers say

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Rotavirus News and Research

Latest Rotavirus News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in